HR
GOSS icon

Howe & Rusling’s Gossamer Bio GOSS Stock Holding History

Howe & Rusling’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100
Closed -$1K – 1112
2022
Q2 		$1K Buy
+100
New +$775 ﹤0.01% 949

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $5.91B AUM 42.42% 1-Year Est. Return

Howe & Rusling's GOSS Position: Q3 2022 in Review

Howe & Rusling sold out of Gossamer Bio (GOSS) in Q3 2022, closing a stake of 100 shares — an estimated $1K sold.

Howe & Rusling first reported a position in GOSS in Q2 2022 and held it in 1 quarter. The position peaked at $1K in Q2 2022. 160 funds tracked by Wall St. Rank hold GOSS as of Q3 2022.

  • Howe & Rusling reported no remaining Gossamer Bio position as of Q3 2022 after selling out during the quarter.
  • Howe & Rusling sold 100 Gossamer Bio shares in Q3 2022, an estimated $1K.
  • Howe & Rusling first reported a position in Gossamer Bio in Q2 2022 and held it in 1 quarter.
  • Howe & Rusling's Gossamer Bio position peaked at $1K in Q2 2022.
  • 160 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2022.

Based on Howe & Rusling's 13F filing for Q3 2022, filed 14 Nov 2022.